← FDA Drug Approvals (Drugs@FDA)
BENDAMUSTINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NANG KUANG PHARM CO · Approved 2023-06-07
Drug application
- FDA Application #
ANDA206554- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BENDAMUSTINE HYDROCHLORIDE
- Generic name
- Bendamustine Hydrochloride
- Active ingredients
- BENDAMUSTINE HYDROCHLORIDE
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- NANG KUANG PHARM CO
- First approval
- 2023-06-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown